Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

34 results about "Protein Sa" patented technology

Malus xiaojinensis Cheng et Jiang MxHA5 protein, and coding gene and application thereof

InactiveCN102559631AImprove solubilityIncrease resistance to iron deficiencyFungiBacteriaIonProtein Sa
The invention discloses a malus xiaojinensis Cheng et Jiang MxHA5 protein, and a coding gene and application thereof. The protein provided by the invention is protein (a) or protein (b), wherein the protein (a) has amino acid sequences shown as a sequence 1 in a sequence table; and the protein (b) has an amino acid residue sequence which is derived from the sequence 1 by substituting and / or losing and / or adding one or more amino acid residues and is related with the P type H<+>-ATPase enzymatic activity in plant. The MxHA5 protein provided by the invention has an important effect of adjusting ion-deficient stressed plant, and the invention further provides good theoretical basis for the research on the ion-deficiency resistance of malus xiaojinensis Cheng et Jiang, and has significance to cultivation of stress-tolerant plant.
Owner:CHINA AGRI UNIV

Prokaryotic expression vector of Pseudomonas putida glutathione-independent formaldehyde dehydrogenase and construction method and application thereof

The invention discloses a prokaryotic expression vector pET28a-PADH for efficiently expressing Pseudomonas putida glutathione-independent formaldehyde dehydrogenase protein. The vector is a prokaryotic expression vector containing a Pseudomonas putida glutathione-independent formaldehyde dehydrogenase gene (PADH). In the invention, the PADH gene is cloned from Pseudomonas putida, and the expression of the PADH gene in colon bacillus is controlled by using a T7 promoter; 40 percent of expressed recombinant protein exists in a supernate in a soluble mode (accounting for 30 percent of soluble total protein of the colon bacillus), and 60 percent of expressed recombinant protein exists in an inclusion body; the high-purity PADH recombinant protein can be easily obtained from the upper inclusion body through tapping and purification and can be used as an antigen used for preparing a PADH specific antibody. The PADH recombinant protein with activity can be easily purified from the soluble total protein of the colon bacillus by affinity chromatography and is used for the production and the physiological-biochemical characteristic analysis of PADH enzyme preparations.
Owner:KUNMING UNIV OF SCI & TECH

Modified leukotoxin gene and protein

InactiveUS7304151B2Devoid of toxic activityImprove the level ofAntibacterial agentsBacteriaWhite blood cellMANNHEIMIA HAEMOLYTICA
The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.
Owner:GUELPH UNIV OF

UGD gene in kelp, protein thereof and application

The invention belongs to the technical field of biology, particularly belongs to the field of genetic engineering, and more particularly relates to UGD gene in kelp, protein thereof and application. the UGD gene is from the kelp and is named as SjaUGD gene, and a nucleotide sequence of the SjaUGD gene is a sequence shown as SEQ ID NO:1. The invention further provides GDP-mannose-6-dehydrogenase which is coded by the SjaUGD gene, an amino acid sequence of GDP-mannose-6-dehydrogenase is a sequence shown as SEQ ID NO:2 while specific activity of the same is 7.99nanokatals.mg-1, and GDP-mannose-6-dehydrogenase has wider optimum reaction temperature range and higher thermostability. Excellent gene resources and enzyme resources are provided for biological preparation of algin.
Owner:青岛海大蓝科生物科技有限公司

Dermatophagoides farina allergen Der f9 gene coded protein and application thereof

The invention discloses dermatophagoides farina allergen Der f9 gene recombinant protein and application thereof. The amino acid sequence of the recombinant protein is shown in SEQ ID No:2. The invention further discloses a preparation method and application of the recombinant protein. The dermatophagoides farina allergen Der f9 gene recombinant protein and the preparation method and application thereof have the advantages that a dermatophagoides farina allergen Der f9 full-length gene sequence is obtained, the recombinant protein is prepared according to the gene sequence, and the coded recombinant protein is high in purity, good in specificity and high in yield. The dermatophagoides farina allergen Der f9 gene recombinant protein can be applied to diagnosing whether a patient suffers from allergic diseases caused by a dermatophagoides farina allergen ninth component.
Owner:崔玉宝

Antibody like protein

A general method and recombinant nucleic acid sequences, by means which the method selects a recombinant protein containing an FHA domain for binding a target molecule from a library proteins with a high-throughput method of creating protein variations within the FHA domain in non-conserved or non-structural sequences of the FHA scaffold, and the library may also be in the form of a phagemid or phage library wherein the ALP nucleic acid sequence is inserted into a vector capable of allowing the vector and expressed ALP protein from being virally packaged, and the recombinant nucleic acid sequences which are randomly mutated at varying non-conserved or non-structural FHA domain sequences.
Owner:IDEA ORCHARD LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products